Boston Scientific (NYSE:BSX) Announces Robust Q4 Results With Increased Sales And Net Income
Boston Scientific (NYSE:BSX) experienced a 6% decline in stock price over the last quarter, amid a period of market uncertainty driven by new tariffs imposed by the U.S. and retaliatory measures from China, which caused volatility in global markets. Despite announcing robust fourth-quarter results with increased sales and net income, along with optimistic full-year guidance, the company's shares were not immune to the broader market downturn. The decision of board member Charles J...